Related Experiment Videos
Salvage chemotherapy for recurrent Ewing's sarcomas
T Ozaki1, S Sugihara, M Hamada
1Department of Orthopaedic Surgery, Okayama University Medical School, Japan.
Neoplasma
|January 1, 1995
Summary
Recurrent Ewing sarcoma can be treated effectively. A combination chemotherapy regimen including ifosfamide induced second remissions in all four patients with metastatic Ewing sarcoma.
Area of Science:
- Pediatric Oncology
- Medical Chemotherapy
- Sarcoma Research
Background:
- Ewing sarcoma frequently metastasizes and recurs after initial treatment.
- Ifosfamide has shown promise in treating recurrent Ewing sarcoma.
- Effective salvage chemotherapy is crucial for improving outcomes in metastatic Ewing sarcoma.
Purpose of the Study:
- To evaluate the efficacy of a specific chemotherapy regimen in patients with recurrent metastatic Ewing sarcoma.
- To assess the potential of inducing second remissions in refractory cases.
Main Methods:
- A combination chemotherapy regimen including ifosfamide, etoposide, pirarubicin, and cyclophosphamide was administered.
- The treatment was given to a small cohort of 4 patients with recurrent metastatic Ewing sarcoma.
Main Results:
- All 4 patients achieved a second remission.
- The combination regimen demonstrated high efficacy in this small group.
Conclusions:
- The studied chemotherapy regimen is effective in inducing second remissions in patients with recurrent metastatic Ewing sarcoma.
- This approach offers a potential treatment option for refractory disease.